Patients most likely to benefit from GLP-1 therapy for fat reduction include those with a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater with weight-related conditions such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
Andrews DA, Yang L, Low PS
Monocytes/macrophages have been found to massively infiltrate synovial membranes 51 and be central to the pathophysiology of inflammation
Will GLP-1RAs be the latest medication to affect a broad array of physiologic process and end up improving not just metabolic but also lung health?
Simental-MendaLEShahNSathyapalanTMajeedMOrekhovANJamialahmadiTet al
A comprehensive approach to treating both conditions typically involves removing trigger foods, addressing bacterial overgrowth with antimicrobials (herbal or conventional), and restoring gut health with probiotics